Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation

BACKGROUND. The clinical management of chronic hepatitis B virus (HBV) patients is based exclusively on virological parameters that cannot independently determine in which patients nucleos(t)ide-analogue (NUC) therapy can be safely discontinued. NUCs efficiently suppress viral replication, but do no...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Rivino, Laura, Le Bert, Nina, Gill, Upkar S., Kunasegaran, Kamini, Cheng, Yang, Tan, Damien Z.M., Becht, Etienne, Hansi, Navjyot K., Foster, Graham R., Su, Tung-Hung, Tseng, Tai-Chung, Lim, Seng Gee, Kao, Jia-Horng, Newell, Evan W., Kennedy, Patrick T.F., Bertoletti, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2018
Assuntos:
Clinical Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5785266/
https://ncbi.nlm.nih.gov/pubmed/29309050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI92812
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados